O'Boyle Graeme, Brain John G, Kirby John A, Ali Simi
Applied Immunobiology and Transplantation Research Group, Institute of Cellular Medicine, Faculty of Medical Sciences, University of Newcastle, Newcastle NE2 4HH, UK.
Mol Immunol. 2007 Mar;44(8):1944-53. doi: 10.1016/j.molimm.2006.09.033. Epub 2006 Nov 1.
The chemokine receptor CCR2 binds four pro-inflammatory monocyte chemoattractant proteins, designated MCP1/CCL2, MCP2/CCL8, MCP3/CCL7 and MCP4/CCL13. This study demonstrates the important biology of this receptor during the response to the chemokine milieu. Competitive chemotaxis and calcium flux assays were performed utilising mixtures of chemokines to assess a hierarchal arrangement of chemokine prepotency; these demonstrated that the MCP2-CCR2 interaction is able to supersede signals generated by RANTES, another pro-inflammatory chemokine, or the homeostatic chemokine SDF1. These observations were validated using three physiologically relevant monocytic cell lines. Having identified the importance of CCR2, experiments were then performed to examine the signal transduction processes coupled to this receptor. G protein coupling was initially examined; Cholera toxin reduced the chemotactic response to MCP2 (p<0.001), whilst the response to the other MCP chemokines remained normal. The response to MCP2 was uniquely inhibited by elevated concentrations of cAMP and, unlike MCP1, 3 and 4 (p<0.05), MCP2 failed to inhibit adenylate cyclase. Expression of dominant negative H-ras demonstrated that each MCP chemokine required active ras in order to elicit ERK activation and a chemotactic response. Unlike MCP1, MCP2 failed to induce nuclear translocation of activated ERK1 or subsequent induction of c-Myc expression. Akt activation also showed ligand-specific differences, with MCP2 producing a delayed response compared to the other MCP chemokines. Together these data highlight the importance of CCR2 and suggest that it is a powerful tool for fine tuning the immune response.
趋化因子受体CCR2可结合四种促炎性单核细胞趋化蛋白,分别命名为MCP1/CCL2、MCP2/CCL8、MCP3/CCL7和MCP4/CCL13。本研究证明了该受体在对趋化因子环境的反应过程中的重要生物学特性。利用趋化因子混合物进行竞争性趋化性和钙流测定,以评估趋化因子优势的层次排列;结果表明,MCP2-CCR2相互作用能够取代由另一种促炎性趋化因子RANTES或稳态趋化因子SDF1产生的信号。这些观察结果在三种生理相关的单核细胞系中得到了验证。在确定了CCR2的重要性后,随后进行实验以研究与该受体偶联的信号转导过程。首先检测了G蛋白偶联情况;霍乱毒素降低了对MCP2的趋化反应(p<0.001),而对其他MCP趋化因子的反应保持正常。对MCP2的反应被升高的cAMP浓度特异性抑制,并且与MCP1、3和4不同(p<0.05),MCP2未能抑制腺苷酸环化酶。显性负性H-ras的表达表明,每种MCP趋化因子都需要活性ras才能引发ERK激活和趋化反应。与MCP1不同,MCP2未能诱导活化的ERK1的核转位或随后的c-Myc表达诱导。Akt激活也表现出配体特异性差异,与其他MCP趋化因子相比,MCP2产生延迟反应。这些数据共同突出了CCR2的重要性,并表明它是微调免疫反应的有力工具。